Neurodegenerative Diseases

• CLINICAL_TRIALS research · 2014-08-07
  Clinical Trial Update: Promoting Informed Decision Making Through Advance Care Planning [NA]

  A clinical trial update about a study aimed at promoting informed decision making through advance care planning for individuals with dementi…

• CLINICAL_TRIALS trial_result · 2014-04-10
  Clinical Trial Update: Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects [Phase 1]

  Phase 1 study in healthy subjects evaluated biodistribution and safety of a radiopharmaceutical; status completed with initial safety and ph…

• CLINICAL_TRIALS trial_result · 2014-04-09
  Clinical Trial Update: Yogic Breathing Changes Salivary Components [NA]

  This completed clinical trial examined whether yogic breathing changes salivary components.

• CLINICAL_TRIALS trial_result · 2013-09-30
  Clinical Trial Update: Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease [Phase 4]

  Clinical trial NCT01662414, sponsored by Chulalongkorn University, evaluated HMS 90 undenatured cysteine-rich whey protein isolate in Parkin…

• FDA approval · 2012-11-28
  FDA Approved: FLUDEOXYGLUCOSE F18 — Supplemental Application (THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH)

  FDA has approved a supplemental application for Fludeoxyglucose F-18, a PET radiopharmaceutical, reflecting an update to its labeling and/or…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-10-01
  Clinical Trial Update: The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

  This clinical trial update reports the long-term safety and efficacy follow-up of subjects who completed the Phase I study of Neurostem-AD.